FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095525 [Registered on: 01/10/2025] Trial Registered Prospectively
Last Modified On: 29/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Testing Marigold Gel Against Clindamycin Gel to Treat Pittaj Yonivyapad (Bacterial Vaginosis) in Women.  
Scientific Title of Study   Evaluation Of Compartive Efficacy Of Marigold ( Tagetes erecta L.) Vaginal Gel Versus Clindamycin Vaginal Gel In Treatment Of Pittaj Yonivyapad (Bacterial Vaginosis)-A Randomized Controlled Trial. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR MITALI DABHADE 
Designation  PG SCHOLAR 
Affiliation  MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTER SALOD WARDHA 
Address  Room No. 9 Department Of Prasuti Tantra And Strirog Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod(H) Wardha MAHARASHTRA 442001 India Wardha MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  9156004789  
Fax    
Email  drmitalidabhade@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SHILPA JAMDADE 
Designation  ASSOCIATE PROFESSOR 
Affiliation  MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTER SALOD WARDHA 
Address  Room No. 9 Department Of Prasuti Tantra And Strirog Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod(H) Wardha MAHARASHTRA 442001 India Wardha MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  9769493806  
Fax    
Email  dr.shilpajamdade@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR MITALI DABHADE 
Designation  PG SCHOLAR 
Affiliation  MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTER SALOD WARDHA 
Address  Room No. 9 Department Of Prasuti Tantra And Strirog Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod(H) Wardha MAHARASHTRA 442001 India Wardha MAHARASHTRA 442001 India

Wardha
MAHARASHTRA
442001
India 
Phone  9156004789  
Fax    
Email  drmitalidabhade@gmail.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H), Wardha Dist Wardha, Maharashtra, India 442001 
 
Primary Sponsor  
Name  MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTER SALOD WARDHA 
Address  Room No. 9 Department Of Prasuti Tantra And Strirog Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod(H) Wardha, MAHARASHTRA 442001 India Wardha, MAHARASHTRA 442001 India  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR MITALI DABHADE  MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTER SALOD WARDHA  Room No. 9 Department Of Prasuti Tantra And Strirog Mahatma Gandhi Ayurved College, Hospital and Research Centre, Salod(H) Wardha MAHARASHTRA 442001 India Wardha MAHARASHTRA 442001 India
Wardha
MAHARASHTRA 
09156004789

drmitalidabhade@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Mahatma Gandhi Ayurved College, Hospital and Research Centre Institutional Committee, Salod(H) Wardha, Maharashtra 442001  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N74||Female pelvic inflammatory disorders in diseases classified elsewhere. Ayurveda Condition: PITTAJA-YONIROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Clindamycin Vaginal Gel--Clindamycin Vaginal Gel will be given for intravaginal application for the Bacterial Vaginosis for 7 days in adequate quantity on 30 subjects
2Intervention ArmDrugClassical(1) Medicine Name: MARIGOLD (TAGETES ERECTA L) VAGINAL GEL, Reference: RAJNIGHANTU, Route: Vaginal, Dosage Form: Malahara/ Ointment/ Balm, Dose: 2.5(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Patients willing to give written consent to participation in research work.
Diagnosed patients of pittaj yonivyapad (bacterial vaginosis).
Between the age of 18 to 45 years and married irrespective of caste religion and socioeconomic background.
 
 
ExclusionCriteria 
Details  Pregnancy, PNC mother, menstruating women, menopausal women.
Patient diagnosed with PID, pyrexia, diabetes, HIV, and VDRL.
Use of antibiotics or antifungal agents in the past 14 days.
Known allergy to marigold.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the Efficacy Of Marigold (Tagetes erecta L.) Vaginal Gel Versus Clindamycin Vaginal Gel In Treatment Of Pittaj Yonivyapad (Bacterial Vaginosis)  0th day 5th day 7th day 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the Efficacy Of Marigold (Tagetes erecta L.) Vaginal Gel Versus Clindamycin Vaginal Gel In Treatment Of Pittaj Yonivyapad (Bacterial Vaginosis)  0th day 5th day 7th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   10/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The volunteer will be informed about the study protocol. Willing participants will be randomly selected as per computer generated table. Clinical research format will be prepared and validated. Prior to the study approval will be taken from IEC MGACHRC Salod (H) Wardha and CTRI registration will be done. After selection each participant will be tested individually and selected according to selection criteria. They are divided into two groups the trial is a open labelled standard control equivalence clinical trial. It will include a 7 days treatment period and assessment during treatment on 0th 5th 7th day and follow up on 14th day.

 
Close